Skip to main content

Table 4 MCTD clinical parameters significantly associated with miR-146a rs2910164 G/C

From: Association study between immune-related miRNAs and mixed connective tissue disease

Scleroderma

miR-146a rs2910164 G/C

n (%)

Model

p

OR (95% CI)

95% CI

  Genotype

GG

GC

CC

CC + GC vs GG

0.14

2.06 (0.88–4.8)

  

   Scleroderma

15 (27.78)

15 (38)

4 (100)

GG + GC vs CC

0.01

18.74

0.9773

359.2678

   Without scleroderma

39 (72.22)

24 (62)

0 (0)

CC + GG vs GC

0.72

1.28

0.55

2.99

  Allele

G

C

 

CC vs GG

0.04

22.94

1.1646

451.6701

   Scleroderma

45 (31)

23 (49)

 

GC vs GG

0.27

1.63

0.68

3.91

   Without scleroderma

102 (69)

24 (51)

 

C vs G

0.02

2.17

1.11

4.25

Lymphadenopathy

miR-146a rs2910164 G/C

n (%)

Model

p

OR

95% CI

  Genotype

GG

GC

CC

CC + GC vs GG

0.005

0.21

0.07

0.61

   Lymphadenopathy

21 (38.89)

5 (13)

0 (0)

GG + GC vs CC

0.57

0.283

0.0147

5.4407

   Without lymphadenopathy

33 (61.11)

34 (87)

4 (100)

CC + GG vs GC

0.01

0.26

0.09

0.76

  Allele

G

C

 

CC vs GG

0.24

0.1731

0.0089

3.3799

   Lymphadenopathy

47 (32)

5 (11)

 

GC vs GG

0.008

0.23

0.08

0.68

   Without lymphadenopathy

100 (68)

42 (89)

 

C vs G

0.006

0.25

0.09

0.68

  1. n number of patients with clinical manifestation; p< 0.05 is considered significant, indicated in bold; p value obtained from χ2 or Fisher exact test